Cargando…

Unbalanced production of LTB(4)/PGE(2) driven by diabetes increases susceptibility to cutaneous leishmaniasis

Poorly controlled diabetes mellitus leads to several comorbidities, including susceptibility to infections. Hyperglycemia increases phagocyte responsiveness, however immune cells from people with diabetes show inadequate antimicrobial functions. We and others have shown that aberrant production of l...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bonyek-Silva, Icaro, Nunes, Sara, Santos, Reinan L., Lima, Filipe R., Lago, Alexsandro, Silva, Juliana, Carvalho, Lucas P., Arruda, Sergio M., Serezani, Henrique C., Carvalho, Edgar M., Brodskyn, Claudia I., Tavares, Natalia M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7473187/ https://www.ncbi.nlm.nih.gov/pubmed/32525457 http://dx.doi.org/10.1080/22221751.2020.1773744

Ejemplares similares

Molecular Aspects of Dendritic Cell Activation in Leishmaniasis: An Immunobiological View
por: Tibúrcio, Rafael, et al.
Publicado: (2019)

LTB(4)-Driven Inflammation and Increased Expression of ALOX5/ACE2 During Severe COVID-19 in Individuals With Diabetes
por: Bonyek-Silva, Icaro, et al.
Publicado: (2021)

Transcriptome Analysis Identifies the Crosstalk between Dendritic and Natural Killer Cells in Human Cutaneous Leishmaniasis
por: Nunes, Sara, et al.
Publicado: (2023)

Diabetes Modifies the Clinic Presentation of Cutaneous Leishmaniasis
por: Lago, Alexsandro S, et al.
Publicado: (2020)

Metformin promotes susceptibility to experimental Leishmania braziliensis infection
por: Lima, Filipe Rocha, et al.
Publicado: (2020)

Opposing roles of LTB(4) and PGE(2) in regulating the inflammasome-dependent scorpion venom-induced mortality
por: Zoccal, Karina F., et al.
Publicado: (2016)

Cytokine gene regulation by PGE(2), LTB(4) and PAF
por: Rola-Pleszczynski, M., et al.
Publicado: (1992)

Clinical Profile and Diagnosis of Recurrent Cutaneous Leishmaniasis
por: Arruda, Sérgio, et al.
Publicado: (2023)

Integrated Analysis Reveals That miR-193b, miR-671, and TREM-1 Correlate With a Good Response to Treatment of Human Localized Cutaneous Leishmaniasis Caused by Leishmania braziliensis
por: Nunes, Sara, et al.
Publicado: (2018)

The Role of CD4 and CD8 T Cells in Human Cutaneous Leishmaniasis
por: da Silva Santos, Claire, et al.
Publicado: (2014)

Localized skin inflammation during cutaneous leishmaniasis drives a chronic, systemic IFN-γ signature
por: Farias Amorim, Camila, et al.
Publicado: (2021)

Blockade of TLR2 and TLR4 Attenuates Inflammatory Response and Parasite Load in Cutaneous Leishmaniasis
por: Carneiro, Pedro Paulo, et al.
Publicado: (2021)

Cutaneous Manifestations of Human and Murine Leishmaniasis
por: Scorza, Breanna M., et al.
Publicado: (2017)

Prostaglandin E2 contributes to L. braziliensis survival and therapeutic failure in cutaneous leishmaniasis
por: Nascimento, Maurício T., et al.
Publicado: (2023)

Characterization of the Histopathologic Features in Patients in the Early and Late Phases of Cutaneous Leishmaniasis
por: Saldanha, Maíra G., et al.
Publicado: (2017)

Clinical and histopathologic features of canine tegumentary leishmaniasis and the molecular characterization of Leishmania braziliensis in dogs
por: Lago, Jamile, et al.
Publicado: (2019)

The miRNA 361-3p, a Regulator of GZMB and TNF Is Associated With Therapeutic Failure and Longer Time Healing of Cutaneous Leishmaniasis Caused by L. (viannia) braziliensis
por: Lago, Tainã S., et al.
Publicado: (2018)

Tissue Damage in Human Cutaneous Leishmaniasis: Correlations Between Inflammatory Cells and Molecule Expression
por: Saldanha, Maíra Garcia, et al.
Publicado: (2020)

Proteome Profiling of Human Cutaneous Leishmaniasis Lesion
por: da Silva Santos, Claire, et al.
Publicado: (2015)

Dogs Harbor Leishmania braziliensis and Participate in the Transmission Cycle of Human Tegumentary Leishmaniasis
por: Lago, Jamile, et al.
Publicado: (2023)

Development of Cutaneous Leishmaniasis after Leishmania Skin Test
por: Machado, Paulo R., et al.
Publicado: (2011)

Plantar ulcer as an atypical manifestation of cutaneous leishmaniasis()()
por: Tironi, Fernanda de Carvalho, et al.
Publicado: (2021)

Prediabetes Induces More Severe Acute COVID-19 Associated With IL-6 Production Without Worsening Long-Term Symptoms
por: Bonyek-Silva, Icaro, et al.
Publicado: (2022)

Comparative analysis of the tissue inflammatory response in human cutaneous and disseminated leishmaniasis
por: Dantas, Marina Loyola, et al.
Publicado: (2014)

Unbalanced inflammatory reaction could increase tissue destruction and worsen skin infectious diseases – a comparative study of leishmaniasis and sporotrichosis
por: Morgado, F. N., et al.
Publicado: (2018)

Atypical Manifestations of Cutaneous Leishmaniasis in a Region Endemic for Leishmania braziliensis: Clinical, Immunological and Parasitological Aspects
por: Guimarães, Luiz Henrique, et al.
Publicado: (2016)

Cytotoxic activity in cutaneous leishmaniasis
por: Campos, Taís M, et al.
Publicado: (2017)

Multi-omic Analyses of Plasma Cytokines, Lipidomics, and Transcriptomics Distinguish Treatment Outcomes in Cutaneous Leishmaniasis
por: Malta-Santos, Hayna, et al.
Publicado: (2020)

IL-22 Protects against Tissue Damage during Cutaneous Leishmaniasis
por: Gimblet, Ciara, et al.
Publicado: (2015)

Understanding the Mechanisms Controlling Leishmania amazonensis Infection In Vitro: The Role of LTB(4) Derived From Human Neutrophils
por: Tavares, Natalia Machado, et al.
Publicado: (2014)

The Pivotal Role of 5-Lipoxygenase-Derived LTB(4) in Controlling Pulmonary Paracoccidioidomycosis
por: Santos, Patrícia Campi, et al.
Publicado: (2013)

NKG2D promotes CD8 T cell-mediated cytotoxicity and is associated with treatment failure in human cutaneous leishmaniasis
por: Sacramento, Laís A., et al.
Publicado: (2023)

Macrophage-derived LTB(4) promotes abscess formation and clearance of Staphylococcus aureus skin infection in mice
por: Brandt, Stephanie L., et al.
Publicado: (2018)

Forecasting Temporal Dynamics of Cutaneous Leishmaniasis in Northeast Brazil
por: Lewnard, Joseph A., et al.
Publicado: (2014)

Correction: Efficacy of intralesional meglumine antimoniate in the treatment of canine tegumentary leishmaniasis: A Randomized controlled trial
por: Lago, Jamile, et al.
Publicado: (2023)

Evaluation of the Ability of Miltefosine Associated with Topical GM-CSF in Modulating the Immune Response of Patients with Cutaneous Leishmaniasis
por: Peixoto, Fábio, et al.
Publicado: (2020)

Coinfection With Trypanosoma brucei Confers Protection Against Cutaneous Leishmaniasis
por: Pereira, Lais, et al.
Publicado: (2018)

Characterization of Neutrophil Function in Human Cutaneous Leishmaniasis Caused by Leishmania braziliensis
por: Conceição, Jacilara, et al.
Publicado: (2016)

Inhibition of gamma-secretase activity without interfering in Notch signalling decreases inflammatory response in patients with cutaneous leishmaniasis
por: Nascimento, Maurício T., et al.
Publicado: (2021)

In Vivo Safety and Efficacy of Chalcone-Loaded Microparticles with Modified Polymeric Matrix against Cutaneous Leishmaniasis
por: Sousa-Batista, Ariane de J., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8brm9s0mcpqpii2egp1cn6q9lh